January 2018 in “International journal of medical biochemistry” This study found that female patients with telogen effluvium had significantly lower levels of serum ferritin, folate, and vitamin B12 compared to the control group.
January 2025 in “BMC Nephrology” This study reported that 83.1% of patients with end-stage renal disease on hemodialysis experienced skin conditions, with xerosis affecting 63.6%, pruritis 36.4%, and notable occurrences of nail and oral anomalies, indicating a need for targeted dermatological management to improve patients' quality of life.
January 2018 in “Journal of Crohn s and Colitis” This study found that high-dose intravenous ferric carboxymaltose may reduce inflammatory activity in patients with inflammatory bowel disease and iron deficiency anaemia, as evidenced by decreased CRP levels and improved clinical disease indices.
In this study, GV-350 treatment over three months improved iron status and reduced the impact of Telogen Effluvium on quality of life among 20 iron-deficient women, with no adverse events reported.
March 2026 in “International Journal of Clinical Dermatology” This study found that all 26 patients with specific skin lesions, primarily young females, were confirmed to have iron deficiency anemia after ruling out other possible causes such as zinc deficiency and pellagra, highlighting the importance of considering anemia as a diagnosis in such cases.